Recently there have been many new reports showing the relationship between gut microbiota and various diseases. In this study, we collected feces from kidney and urothelial cancer patients and examined whether the composition of gut microbiota affects metastasis and cancer type of patients with these cancers. We also investigated whether there are differences in the composition of the gut microbiota depending on the values of the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR). It is reported that NLR and PLR reflect the inflammatory response and the immune status, and it becomes a prognostic predictor in various cancer types. From April 2018 to September 2018, a total of 54 patients were enrolled in Showa University hospital. We analyzed gut microbiota using 16S ribosomal RNA gene by next generation sequencer. We found a significant difference between
Clostridiaceae and
Verrucomicrobiaceae in the comparison between kidney and urothelial cancer.
Peptostreptococcaceae was significantly greater in the absence of metastasis of urothelial carcinoma. A significant difference was found in
Rikenellaceae and
Veillonellaceae in comparison with PLR ≧ 210 and PLR <210. The diversity of intestinal bacteria was poor in kidney and urothelial metastatic cancer compared without metastatic cancer. In this study, we found differences in the gut microbiota according to cancer type and the presence or absence of metastasis. Gut microbiota may be useful for the prevention of disease, treatment target, and prediction factor of a drug’s effects. Further accumulation of research on this topic is necessary.
View full abstract